StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
352
This month
4
This year
20
Publishing Date
2024 - 04 - 09
2
2024 - 04 - 02
2
2024 - 03 - 05
2
2024 - 01 - 30
3
2023 - 12 - 20
2
2023 - 12 - 13
2
2023 - 12 - 12
2
2023 - 11 - 08
2
2023 - 11 - 07
2
2023 - 10 - 26
2
2023 - 10 - 25
2
2023 - 10 - 03
3
2023 - 09 - 18
2
2023 - 09 - 07
2
2023 - 08 - 16
2
2023 - 07 - 17
6
2023 - 05 - 16
2
2023 - 05 - 08
2
2023 - 05 - 04
2
2023 - 04 - 26
3
2023 - 03 - 15
2
2023 - 02 - 16
2
2023 - 01 - 31
2
2023 - 01 - 19
2
2022 - 12 - 20
2
2022 - 10 - 13
2
2022 - 09 - 07
2
2022 - 08 - 16
2
2022 - 08 - 03
2
2022 - 08 - 01
3
2022 - 06 - 10
2
2022 - 05 - 23
2
2022 - 04 - 26
2
2022 - 03 - 30
4
2022 - 03 - 07
2
2022 - 01 - 24
2
2021 - 12 - 13
2
2021 - 11 - 18
2
2021 - 11 - 17
2
2021 - 11 - 11
2
2021 - 10 - 25
2
2021 - 09 - 30
2
2021 - 09 - 28
2
2021 - 08 - 23
2
2021 - 08 - 05
2
2021 - 07 - 22
2
2021 - 06 - 30
2
2021 - 03 - 29
2
2021 - 03 - 17
3
2021 - 02 - 03
3
2021 - 02 - 02
3
2021 - 01 - 06
2
2020 - 12 - 17
3
2020 - 12 - 08
2
2020 - 12 - 04
2
2020 - 12 - 03
3
2020 - 11 - 12
1
2020 - 10 - 13
1
2020 - 08 - 14
1
2018 - 08 - 09
1
Sector
Commercial services
6
Consumer durables
1
Consumer non-durables
6
Consumer services
1
Distribution services
2
Electronic technology
4
Energy minerals
3
Finance
6
Health care and social assistance
1
Health services
1
Health technology
204
Industrial services
3
Information
1
Manufacturing
37
Mining, quarrying, and oil and gas extraction
1
N/a
6
Non-energy minerals
13
Process industries
5
Producer manufacturing
5
Professional, scientific, and technical services
18
Real estate and rental and leasing
1
Retail trade
3
Technology services
8
Transportation
3
Transportation and warehousing
1
Utilities
3
Tags
America
194
Automotive
239
Bioscience
208
Biotech-bay
293
Biotech-beach
255
Business
1223
China
198
Conference
659
Corporation
796
Covid
341
Covid-19
340
Diagnostics
206
Drug
196
Earnings
2048
Energy
664
Esg
222
Europe
223
Events
258
Financial
7679
Financial results
4356
First
275
Food
249
Genetown
237
Global
4119
Grant
403
Granted
241
Grants
489
Group
695
Growing
470
Growth
2519
Health
404
Impact
241
Iot
261
Management
313
Market
6710
Medical
243
N/a
36808
Nasdaq
809
Pharm-country
250
Pharma
384
Pharmaceuticals
557
Positive
352
Program
385
Reach
363
Report
15911
Research
1586
Results
21200
Sales
453
Services
358
Smart
250
Software
222
Solutions
242
System
259
Technology
593
Therapeutics
1462
Treatment
247
Trends
240
Trial
431
Update
1726
Year
3450
Entities
89bio, inc.
2
Adaptimmune therapeutics plc
3
Allogene therapeutics, inc.
3
Alnylam pharmaceuticals, inc.
12
Altamira therapeutics ltd
2
Alterity therapeutics limited
2
Apellis pharmaceuticals, inc.
2
Aquestive therapeutics, inc.
7
Argenx se
2
Arrival
3
Artelo biosciences, inc.
3
Athenex, inc.
2
Avidity biosciences, inc.
2
Bio-key international, inc.
2
Biogen inc.
2
Bioxcel therapeutics, inc.
2
Blackrock, inc.
2
Briacell therapeutics corp.
2
Caribou biosciences inc
2
Clene inc
2
Concert pharmaceuticals, inc.
2
Connect biopharma holdings ltd - adr
2
Controladora vuela compania de aviacion, s.a.b. de c.v.
2
Crinetics pharmaceuticals, inc.
2
Diffusion pharmaceuticals inc.
3
Digihost technology inc.
3
Effector therapeutics inc
2
Eli lilly and company
3
Eloxx pharmaceuticals, inc.
2
Enanta pharmaceuticals, inc.
2
Endeavour silver corporation
2
Enlivex therapeutics ltd.
2
Enveric biosciences inc
2
Evelo biosciences, inc.
2
Eyepoint pharmaceuticals, inc.
4
First majestic silver corp.
2
Flotek industries, inc.
2
Fusion pharmaceuticals inc.
3
Galectin therapeutics inc.
5
Gartner, inc.
3
Genprex, inc.
3
High tide inc.
5
Immunic, inc.
3
Immutep limited
3
Ionis pharmaceuticals, inc.
3
Johnson & johnson
5
Kering
3
Morphic holding, inc.
3
Neurosense therapeutics ltd.
5
Nrx pharmaceuticals inc
3
Oramed pharmaceuticals inc.
3
Outlook therapeutics, inc.
3
Pfizer, inc.
5
Regeneron pharmaceuticals, inc.
5
Roivant sciences ltd.
4
Sanofi
9
Transcode therapeutics inc
7
Verona pharma plc
3
Vyne therapeutics inc.
3
Yamana gold inc.
3
Symbols
ADAP
3
AG
2
ALLO
3
ALNY
12
APLS
2
AQST
7
ARGX
2
ARTL
3
ARVL
3
ATHE
2
ATNX
2
AUY
3
BCTX
2
BIIB
2
BKYI
2
BLK
2
BTAI
2
CLNN
2
CNCE
2
CNTB
2
CRBU
2
CRNX
2
CYTO
2
DFFN
3
DGHI
3
EFTR
2
ELOX
2
ENLV
2
ENTA
2
ENVB
2
ETNB
2
EVLO
2
EXK
2
EYPT
4
FTK
2
FUSN
3
GALT
5
GNPX
3
HITI
5
IMMP
3
IMUX
3
IONS
3
IT
3
JNJ
5
LLY
3
MORF
3
NRSN
5
NRXP
3
ORMP
3
OTLK
3
PFE
5
PPRUF
3
PPRUY
3
REGN
5
RNAZ
7
ROIV
4
SNY
9
SNYNF
9
VRNA
3
VYNE
3
Exchanges
Amex
5
Nasdaq
291
Nyse
64
Crawled Date
2024 - 04 - 09
2
2024 - 04 - 02
2
2024 - 03 - 05
2
2024 - 01 - 30
3
2023 - 12 - 20
2
2023 - 12 - 13
2
2023 - 12 - 12
2
2023 - 12 - 04
2
2023 - 11 - 08
2
2023 - 11 - 07
2
2023 - 10 - 26
2
2023 - 10 - 25
2
2023 - 10 - 03
3
2023 - 09 - 18
2
2023 - 09 - 07
2
2023 - 08 - 16
2
2023 - 07 - 17
6
2023 - 05 - 16
2
2023 - 05 - 09
2
2023 - 05 - 04
2
2023 - 04 - 26
3
2023 - 03 - 15
2
2023 - 02 - 16
2
2023 - 01 - 31
2
2023 - 01 - 19
2
2022 - 12 - 20
2
2022 - 10 - 13
2
2022 - 09 - 07
2
2022 - 08 - 16
2
2022 - 08 - 03
2
2022 - 08 - 01
3
2022 - 06 - 29
2
2022 - 06 - 10
2
2022 - 05 - 23
2
2022 - 04 - 26
2
2022 - 03 - 30
5
2022 - 03 - 07
2
2022 - 01 - 24
2
2021 - 12 - 13
2
2021 - 11 - 18
3
2021 - 11 - 11
2
2021 - 10 - 25
2
2021 - 09 - 30
2
2021 - 09 - 28
2
2021 - 08 - 23
2
2021 - 08 - 05
2
2021 - 07 - 22
2
2021 - 06 - 30
2
2021 - 03 - 29
2
2021 - 03 - 17
3
2021 - 02 - 03
3
2021 - 02 - 02
3
2021 - 01 - 06
2
2020 - 12 - 17
3
2020 - 12 - 09
1
2020 - 12 - 08
2
2020 - 12 - 05
1
2020 - 12 - 04
2
2020 - 12 - 03
3
2020 - 12 - 01
2
Crawled Time
00:00
7
01:00
4
02:00
3
02:08
1
03:10
1
04:00
2
05:00
3
06:00
4
07:00
8
07:03
1
08:00
5
09:00
3
10:00
5
11:00
29
11:01
1
11:02
1
12:00
49
12:01
3
12:03
1
12:04
1
12:06
1
12:15
3
12:20
13
12:30
9
13:00
38
13:01
3
13:14
1
13:15
4
13:20
6
13:26
1
13:30
9
13:59
1
14:00
19
14:01
1
14:10
1
14:15
4
14:20
2
14:30
3
15:00
9
15:01
1
15:30
4
16:00
9
16:20
1
17:00
6
18:00
8
19:00
6
20:00
16
20:20
2
21:00
12
21:03
1
21:06
1
22:00
13
22:09
1
22:12
2
23:00
9
Source
alteritytherapeutics.com
1
americann.co
1
beamforall.com
1
hightideinc.com
2
ir.anaptysbio.com
1
neurosense.investorroom.com
4
sixthwave.com
1
spacfeed.com
1
www.agtc.com
1
www.aquestive.com
3
www.biospace.com
131
www.diffusionpharma.com
1
www.globenewswire.com
136
www.inventivapharma.com
1
www.izea.com
1
www.prnewswire.com
64
www.vynetherapeutics.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
report
tags :
Positive
save search
Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex® Delivery System for the Treatment of Lung Cancers at the 2024 AACR Annual Meeting
Published:
2024-04-09
(Crawled : 12:30)
- prnewswire.com
GNPX
|
$2.26
-1.74%
14K
|
Health Technology
|
-22.3%
|
O:
2.36%
H:
6.6%
C:
1.32%
reqorsa
lung
report
positive
treatment
system
preclinical
for
meeting
therapy
Galectin Therapeutics Reports the Positive Outcome of the Fifth Data and Safety Monitoring Board Meeting for NAVIGATE Phase 2b/3 Study of Belapectin in Patients with Cirrhotic Portal Hypertension Caused by Metabolic Dysfunction-Associated SteatoHepatitis
Published:
2024-04-09
(Crawled : 12:00)
- globenewswire.com
GALT
|
$3.4
110K
|
Health Technology
|
-7.1%
|
O:
2.19%
H:
6.15%
C:
5.35%
metabolic
positive
for
meeting
hypertension
therapeutics
study
Petros Pharmaceuticals Reports Positive Results in an Initial Cohort Two-Arm Self-Selection (Phase 2-Equivalent) Study for STENDRA(R) (avanafil) as it Pursues OTC Status
Published:
2024-04-02
(Crawled : 14:30)
- biospace.com/
PTPI
|
$0.6812
-3.38%
440K
|
|
Email alert
Add to watchlist
positive
pharmaceuticals
results
study
C-Bond Systems Reports 2023 Highlights Including Record Revenue and Positive Net Income; Company to Host Conference Call on April 3rd
Published:
2024-04-02
(Crawled : 12:30)
- globenewswire.com
CBNT
|
$0.0039
270K
|
Manufacturing
|
-9.3%
|
O:
-11.63%
H:
7.89%
C:
7.89%
conference
company
revenue
positive
Altimmune Announces Positive Lean Mass Preservation Data for Pemvidutide and Reports Fourth Quarter and Full Year 2023 Financial Results
Published:
2024-03-27
(Crawled : 11:00)
- globenewswire.com
ALT
|
$7.18
-4.52%
2.2M
|
Commercial Services
|
-13.06%
|
O:
7.63%
H:
3.33%
C:
-4.51%
year
positive
financial
results
Praxis Precision Medicines Reports Positive Results of PRAX-628 Study Evaluating Photo Paroxysmal Response (PPR) Achieving 100% Response in Treated Patients
Published:
2024-03-26
(Crawled : 11:00)
- globenewswire.com
PRAX
|
$49.65
-5.27%
170K
|
Health Technology
|
3.78%
|
O:
19.9%
H:
11.0%
C:
2.69%
prax-628
precision
positive
photo
response
results
study
IceCure Medical Reports Positive Topline Results From ICE3 Cryoablation Breast Cancer Study: Achievement of 96.39% Recurrence Free Rate Brings Company One Step Closer to Providing Women a Non-Surgical Alternative to Lumpectomy
Published:
2024-03-19
(Crawled : 12:30)
- prnewswire.com
ICCM
|
$1.295
-0.39%
1.4M
|
Manufacturing
|
7.44%
|
O:
2.07%
H:
0.0%
C:
0.0%
free
company
breast
one
positive
cancer
women
topline
medical
alternative
results
High Tide Reports First Quarter 2024 Financial Results Featuring Record Revenue, Record Adjusted EBITDA, and Third Consecutive Quarter of Positive Free Cash Flow as well as Break-Even Net Income
Published:
2024-03-15
(Crawled : 20:00)
- hightideinc.com
HITI
|
$2.24
0.45%
790K
|
Manufacturing
|
Email alert
Add to watchlist
first
free
positive
flow
financial
results
Alibaba Releases Report on Cross-Border Trade's Positive Impact on the U.S. Economy
Published:
2024-03-06
(Crawled : 11:00)
- prnewswire.com
BABA
|
$69.09
-0.75%
9M
|
Retail Trade
|
-3.41%
|
O:
2.96%
H:
0.7%
C:
-0.66%
report
positive
impact
Alnylam Reports Positive KARDIA-2 Topline Study Results Demonstrating Clinically Significant Blood Pressure Reductions When Zilebesiran is Added to Standard of Care Antihypertensives
Published:
2024-03-05
(Crawled : 16:00)
- biospace.com/
SNY
|
$46.24
0.96%
1.2M
|
Health Technology
|
-2.4%
|
O:
1.17%
H:
0.0%
C:
0.0%
ALNY
|
$147.2
0.33%
130K
|
Health Technology
|
-2.21%
|
O:
-0.73%
H:
1.52%
C:
0.5%
positive
blood
care
topline
results
study
CASI Pharmaceuticals Report Positive Interim Phase 1 Data For BI-1206 In The Treatment Of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma In China
Published:
2024-03-05
(Crawled : 12:00)
- prnewswire.com
CASI
|
$2.25
-3.85%
36K
|
Health Technology
|
-53.98%
|
O:
21.93%
H:
10.65%
C:
-8.71%
bi-1206
report
positive
treatment
pharmaceuticals
china
BioCardia Reports Positive Interim Results from Phase III CardiAMP Cell Therapy Heart Failure Trial, with Compelling Data in Subgroup with Elevated NTproBNP Biomarker for Heart Failure
Published:
2024-03-04
(Crawled : 13:00)
- globenewswire.com
BCDA
|
$0.3642
22K
|
Health Technology
|
-37.19%
|
O:
0.03%
H:
1.72%
C:
-21.53%
biomarker
positive
cell
cardiamp
heart
therapy
results
NeuroSense Reports Additional Positive Results from its ALS Phase 2b PARADIGM Trial
Published:
2024-02-21
(Crawled : 13:30)
- neurosense.investorroom.com
NRSN
4 d
|
$1.65
39K
|
|
20.44%
|
O:
-3.65%
H:
0.0%
C:
-5.3%
als
positive
trial
results
Larimar Therapeutics Reports Positive Top-line Data from Phase 2 Dose Exploration Study from 25 mg and 50 mg Cohorts of Nomlabofusp in Patients with Friedreich’s Ataxia
Published:
2024-02-12
(Crawled : 12:00)
- globenewswire.com
LRMR
|
$7.065
-2.42%
85K
|
Health Technology
|
-6.7%
|
O:
-16.24%
H:
26.92%
C:
20.46%
positive
therapeutics
study
GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster
Published:
2024-02-06
(Crawled : 14:00)
- globenewswire.com
GOVX
|
$1.56
1.96%
14K
|
Health Technology
|
-39.53%
|
O:
2.77%
H:
2.69%
C:
1.92%
cm04
covid-19
vaccine
universal
geo-cm04s1
positive
trial
BridgeBio Pharma Shares Positive Results of Single-Arm Phase 3 Study of Acoramidis in Japanese Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Including No Mortality Reported in the Trial at 30 Months
Published:
2024-02-02
(Crawled : 12:00)
- globenewswire.com
BBIO
|
$25.33
0.36%
1M
|
Health Technology
|
-24.23%
|
O:
-1.41%
H:
5.51%
C:
3.26%
pharma
positive
trial
results
study
Sysco Reports Second Quarter EPS Growth, Driven By Increasing Volumes and Positive Operating Leverage
Published:
2024-01-30
(Crawled : 13:00)
- globenewswire.com
SYY
|
$74.73
-1.45%
810K
|
Distribution Services
|
0.88%
|
O:
0.51%
H:
7.17%
C:
6.98%
positive
Nuclear Fuels Reports Positive Drill Results from the Kaycee Uranium Project, Wyoming
Published:
2024-01-30
(Crawled : 12:00)
- prnewswire.com
EU
|
$4.37
-3.53%
-3.66%
1.5M
|
n/a
|
-3.33%
|
O:
0.0%
H:
5.56%
C:
4.67%
nuclear
positive
uranium
results
Kura Oncology Reports Positive Preliminary Ziftomenib Combination Data in Acute Myeloid Leukemia
Published:
2024-01-30
(Crawled : 12:00)
- globenewswire.com
KURA
|
$17.96
-3.39%
310K
|
Health Technology
|
-0.05%
|
O:
-0.54%
H:
23.89%
C:
12.7%
positive
leukemia
NeuroBo Pharmaceuticals Reports Positive Pre-Clinical Safety Data of DA-1241 in Combination with Sitagliptin and Opens Enrollment for Part 2 of Its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of MASH
Published:
2024-01-18
(Crawled : 13:00)
- prnewswire.com
NRBO
|
$3.565
4.85%
10K
|
Health Technology
|
0.59%
|
O:
0.59%
H:
3.24%
C:
0.88%
da-1241
pre-clinical
positive
treatment
pharmaceuticals
trial
← Previous
1
2
3
4
5
6
7
8
9
…
17
18
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
INVO
|
$2.78
265.79%
200M
|
Health Technology
EDBL
|
$7.4
62.64%
12M
|
SINT
|
$0.0366
59.83%
460M
|
Health Technology
RYDE
|
$3.89
42.49%
1.2M
|
n/a
GRTX
|
$0.237
39.41%
13M
|
Health Technology
VNDA
|
$5.28
30.37%
21M
|
Health Technology
VIRX
|
$0.912
27.59%
170K
|
Manufacturing
WISA
4
|
$7.72
26.56%
51M
|
Electronic Technology
LUXH
|
$1.045
26.06%
540K
|
RCAT
|
$1.41
25.89%
3.2M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.